2: Aberrant binding of mutant calreticulin dimers to the thrombopoietin receptor MPL mediates receptor dimerization and leads to constitutive activation of JAK‐STAT signaling, promoting proliferation of MPN cells. This evidence concerns the gene MPL and myeloproliferative neoplasm.